Home > Insider Trading > Filing (0001209191-19-005357)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108205	Curis Inc	CRIS	Biological Products, (No Disgnostic Substances) (2836)	043505116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1400977	E James Dentzer	C/O Curis, Inc. 4 Maguire Road Lexington MA 02421	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-01-23	2,397	$1.09	44,733	No	4	S	Direct
Common Stock	Disposition	2019-01-24	3,094	$1.16	41,639	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

These transactions were effected pursuant to Rule 10b5-1 trading plans to cover tax obligations.
On May 29, 2018, the Company effected a 1-for-5 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
The price reported in Column 4 is a weighted average price for the shares sold. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.17, inclusive. The reporting person undertakes to provide to Curis, Inc., any security holder of Curis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth on this Form 4.